{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T12:19:18Z","timestamp":1772626758776,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1999,11,1]],"date-time":"1999-11-01T00:00:00Z","timestamp":941414400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Genet"],"published-print":{"date-parts":[[1999,11]]},"DOI":"10.1038\/15537","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T08:34:58Z","timestamp":1027672498000},"page":"354-358","source":"Crossref","is-referenced-by-count":435,"title":["Perlecan is essential for cartilage and cephalic development"],"prefix":"10.1038","volume":"23","author":[{"given":"Eri","family":"Arikawa-Hirasawa","sequence":"first","affiliation":[]},{"given":"Hideto","family":"Watanabe","sequence":"additional","affiliation":[]},{"given":"Hiroya","family":"Takami","sequence":"additional","affiliation":[]},{"given":"John R.","family":"Hassell","sequence":"additional","affiliation":[]},{"given":"Yoshihiko","family":"Yamada","sequence":"additional","affiliation":[]}],"member":"297","reference":[{"key":"BFng1199_354_CR1","doi-asserted-by":"crossref","first-page":"22939","DOI":"10.1016\/S0021-9258(18)54445-8","volume":"266","author":"DM Noonan","year":"1991","unstructured":"Noonan, D.M. et al. The complete sequence of perlecan, a basement membrane heparan sulfate proteoglycan, reveals extensive similarity with laminin A chain, low density lipoprotein-receptor, and the neural cell adhesion molecule. J. Biol. Chem. 266, 22939\u201322947 (1991).","journal-title":"J. Biol. Chem."},{"key":"BFng1199_354_CR2","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1042\/bj3020625","volume":"302","author":"RV Iozzo","year":"1994","unstructured":"Iozzo, R.V., Cohen, I.R., Grassel, S. & Murdoch, A.D. The biology of perlecan: the multifaceted heparan sulphate proteoglycan of basement membranes and pericellular matrices. Biochem. J. 302, 625\u2013639 (1994).","journal-title":"Biochem. J."},{"key":"BFng1199_354_CR3","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/0092-8674(94)90031-0","volume":"79","author":"D Aviezer","year":"1994","unstructured":"Aviezer, D. et al. Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis. Cell 79, 1005\u20131013 ( 1994).","journal-title":"Cell"},{"key":"BFng1199_354_CR4","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1242\/jcs.108.7.2663","volume":"108","author":"N SundarRaj","year":"1995","unstructured":"SundarRaj, N., Fite, D., Ledbetter, S., Chakravarti, S. & Hassell, J.R. Perlecan is a component of cartilage matrix and promotes chondrocyte attachment. J. Cell. Sci. 108, 2663\u20132672 (1995).","journal-title":"J. Cell. Sci."},{"key":"BFng1199_354_CR5","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/(SICI)1097-0177(199710)210:2<130::AID-AJA6>3.0.CO;2-H","volume":"210","author":"M Handler","year":"1997","unstructured":"Handler, M., Yurchenco, P.D. & Iozzo, R.V. Developmental expression of perlecan during murine embryogenesis. Dev. Dyn. 210, 130\u2013 145 (1997).","journal-title":"Dev. Dyn."},{"key":"BFng1199_354_CR6","first-page":"181","volume":"11","author":"G Morriss-Kay","year":"1991","unstructured":"Morriss-Kay, G. & Tucket, F. Early events in mammalian craniofacial morphogenesis. J. Craniofac. Genet. Dev. Biol. 11, 181\u2013191 ( 1991).","journal-title":"J. Craniofac. Genet. Dev. Biol."},{"key":"BFng1199_354_CR7","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/ng0395-321","volume":"9","author":"PL Tavormina","year":"1995","unstructured":"Tavormina, P.L. et al. Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3. Nature Genet. 9, 321\u2013328 ( 1995).","journal-title":"Nature Genet."},{"key":"BFng1199_354_CR8","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1097\/00008480-199708000-00021","volume":"9","author":"WA Horton","year":"1997","unstructured":"Horton, W.A. Fibroblast growth factor receptor 3 and the human chondrodysplasias. Curr. Opin. Pediatr. 9, 437\u2013442 (1997).","journal-title":"Curr. Opin. Pediatr."},{"key":"BFng1199_354_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/01202412-199801000-00001","volume":"7","author":"M Weber","year":"1998","unstructured":"Weber, M., Johannisson, T., Thomsen, M., Rehder, H. & Niethard, F.U. Thanatophoric dysplasia type I: new radiologic, morphologic, and histologic aspects toward the exact definition of the disorder. J. Pediatr. Orthop. B 7, 1\u20139 (1998).","journal-title":"J. Pediatr. Orthop. B"},{"key":"BFng1199_354_CR10","doi-asserted-by":"crossref","first-page":"4977","DOI":"10.1242\/dev.125.24.4977","volume":"125","author":"MC Naski","year":"1998","unstructured":"Naski, M.C., Colvin, J.S., Coffin, J.D. & Ornitz, D.M. Repression of hedgehog signaling and BMP4 expression in growth plate cartilage by fibroblast growth factor receptor 3. Development 125, 4977\u20134988 (1998).","journal-title":"Development"},{"key":"BFng1199_354_CR11","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1093\/hmg\/8.1.35","volume":"8","author":"C Li","year":"1999","unstructured":"Li, C. et al. A Lys644Glu substitution in fibroblast growth factor receptor 3 (FGFR3) causes dwarfism in mice by activation of STATs and ink4 cell cycle inhibitors. Hum. Mol. Genet. 8, 35\u2013 44 (1999).","journal-title":"Hum. Mol. Genet."},{"key":"BFng1199_354_CR12","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1002\/(SICI)1096-8628(19980707)78:3<274::AID-AJMG14>3.0.CO;2-C","volume":"78","author":"WR Wilcox","year":"1998","unstructured":"Wilcox, W.R. et al. Molecular, radiologic, and histopathologic correlations in thanatophoric dysplasia. Am. J. Med. Genet. 78, 274\u2013281 (1998).","journal-title":"Am. J. Med. Genet."},{"key":"BFng1199_354_CR13","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/ng0696-233","volume":"13","author":"MC Naski","year":"1996","unstructured":"Naski, M.C., Wang, Q., Xu, J. & Ornitz, D.M. Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia. Nature Genet. 13, 233\u2013237 (1996).","journal-title":"Nature Genet."},{"key":"BFng1199_354_CR14","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/17611","volume":"397","author":"PT Chuang","year":"1999","unstructured":"Chuang, P.T. & McMahon, A.P. Vertebrate Hedgehog signalling modulated by induction of a Hedgehog-binding protein. Nature 397, 617\u2013621 (1999).","journal-title":"Nature"},{"key":"BFng1199_354_CR15","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1007\/s001090050214","volume":"76","author":"A Aszodi","year":"1998","unstructured":"Aszodi, A., Pfeifer, A., Wendel, M., Hiripi, L. & Fassler, R. Mouse models for extracellular matrix diseases. J. Mol. Med. 76, 238\u2013252 (1998).","journal-title":"J. Mol. Med."},{"key":"BFng1199_354_CR16","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/6016","volume":"21","author":"H Watanabe","year":"1999","unstructured":"Watanabe, H. & Yamada, Y. Mice lacking link protein develop dwarfism and craniofacial abnormalities. Nature Genet. 21, 225\u2013229 (1999).","journal-title":"Nature Genet."},{"key":"BFng1199_354_CR17","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/S0092-8674(00)81069-7","volume":"84","author":"C Deng","year":"1996","unstructured":"Deng, C., Wynshaw-Boris, A., Zhou, F., Kuo, A. & Leder, P. Fibroblast growth factor receptor 3 is a negative regulator of bone growth. Cell 84, 911\u2013921 (1996).","journal-title":"Cell"},{"key":"BFng1199_354_CR18","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1002\/ajmg.1320210402","volume":"21","author":"A Ornoy","year":"1985","unstructured":"Ornoy, A., Adomian, G.E., Eteson, D.J., Burgeson, R.E. & Rimoin, D.L. The role of mesenchyme-like tissue in the pathogenesis of thanatophoric dysplasia. Am. J. Med. Genet. 21, 613\u2013630 ( 1985).","journal-title":"Am. J. Med. Genet."},{"key":"BFng1199_354_CR19","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/8756-3282(88)90027-0","volume":"9","author":"WA Horton","year":"1988","unstructured":"Horton, W.A., Hood, O.J., Machado, M.A., Ahmed, S. & Griffey, E.S. Abnormal ossification in thanatophoric dysplasia. Bone 9, 53\u201361 (1988).","journal-title":"Bone"},{"key":"BFng1199_354_CR20","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1126\/science.273.5275.613","volume":"273","author":"A Vortkamp","year":"1996","unstructured":"Vortkamp, A. et al. Regulation of rate of cartilage differentiation by Indian hedgehog and PTH-related protein. Science 273, 613\u2013622 (1996).","journal-title":"Science"},{"key":"BFng1199_354_CR21","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/ng0496-390","volume":"12","author":"JS Colvin","year":"1996","unstructured":"Colvin, J.S., Bohne, B.A., Harding, G.W., McEwen, D.G. & Ornitz, D.M. Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3. Nature Genet. 12, 390\u2013397 ( 1996).","journal-title":"Nature Genet."},{"key":"BFng1199_354_CR22","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/386288a0","volume":"386","author":"WC Su","year":"1997","unstructured":"Su, W.C. et al. Activation of Stat1 by mutant fibroblast growth-factor receptor in thanatophoric dysplasia type II dwarfism. Nature 386, 288\u2013292 (1997).","journal-title":"Nature"},{"key":"BFng1199_354_CR23","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1101\/gad.13.11.1361","volume":"13","author":"M Sahni","year":"1999","unstructured":"Sahni, M. et al. FGF signaling inhibits chondrocyte proliferation and regulates bone development through the STAT-1 pathway. Genes. Dev. 13, 1361\u20131366 (1999).","journal-title":"Genes. Dev."},{"key":"BFng1199_354_CR24","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1126\/science.7536345","volume":"268","author":"DM Ornitz","year":"1995","unstructured":"Ornitz, D.M. et al. FGF binding and FGF receptor activation by synthetic heparan-derived di- and trisaccharides. Science 268, 432 \u2013436 (1995).","journal-title":"Science"},{"key":"BFng1199_354_CR25","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1093\/hmg\/6.11.1899","volume":"6","author":"AL Delezoide","year":"1997","unstructured":"Delezoide, A.L. et al. Abnormal FGFR3 expression in cartilage of thanatophoric dysplasia fetuses. Hum. Mol. Genet. 6, 1899 \u20131906 (1997).","journal-title":"Hum. Mol. Genet."},{"key":"BFng1199_354_CR26","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1128\/MCB.17.4.1938","volume":"17","author":"D Aviezer","year":"1997","unstructured":"Aviezer, D., Iozzo, R.V., Noonan, D.M. & Yayon, A. Suppression of autocrine and paracrine functions of basic fibroblast growth factor by stable expression of perlecan antisense cDNA. Mol. Cell. Biol. 17, 1938\u20131946 ( 1997).","journal-title":"Mol. Cell. Biol."},{"key":"BFng1199_354_CR27","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/0092-8674(91)90011-M","volume":"65","author":"VL Tybulewicz","year":"1991","unstructured":"Tybulewicz, V.L., Crawford, C.E., Jackson, P.K., Bronson, R.T. & Mulligan, R.C. Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene. Cell 65, 1153\u20131163 ( 1991).","journal-title":"Cell"},{"key":"BFng1199_354_CR28","first-page":"153","volume-title":"Methods in Prenatal Toxicology","author":"PW Peters","year":"1977","unstructured":"Peters, P.W. Double staining of fetal skeletons for cartilage and bone. in Methods in Prenatal Toxicology(eds Neubert, D. et al.) 153\u2013154 (Thieme, Stuttgart, 1977)."},{"key":"BFng1199_354_CR29","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/333861a0","volume":"333","author":"K Arahata","year":"1988","unstructured":"Arahata, K. et al. Immunostaining of skeletal and cardiac muscle surface membrane with antibody against Duchenne muscular dystrophy peptide. Nature 333, 861\u2013863 ( 1988).","journal-title":"Nature"},{"key":"BFng1199_354_CR30","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/(SICI)1096-9926(199709)56:3<177::AID-TERA1>3.0.CO;2-Z","volume":"56","author":"MJ Harris","year":"1997","unstructured":"Harris, M.J. & Juriloff, D.M. Genetic landmarks for defects in mouse neural tube closure. Teratology 56, 177\u2013187 (1997).","journal-title":"Teratology"}],"container-title":["Nature Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ng1199_354.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ng1199_354","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ng1199_354.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T19:19:40Z","timestamp":1638386380000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ng1199_354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,11]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1999,11]]}},"alternative-id":["BFng1199_354"],"URL":"https:\/\/doi.org\/10.1038\/15537","relation":{},"ISSN":["1061-4036","1546-1718"],"issn-type":[{"value":"1061-4036","type":"print"},{"value":"1546-1718","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,11]]}}}